Author Index: P
• RESPONSIVENESS OF A BRIEF MEASURE OF SMOKERS' KNOWLEDGE OF LUNG CANCER SCREENING WITH LOW-DOSE COMPUTED TOMOGRAPHY
• ACCEPTABILITY AND EFFICACY OF A VIDEO-BASED PATIENT DECISION AID ABOUT LUNG CANCER SCREENING WITH LOW-DOSE COMPUTED TOMOGRAPHY
• PRIMARY CARE PHYSICIANS' LUNG CANCER SCREENING PRACTICES: COMPARISONS BEFORE AND AFTER THE CENTERS FOR MEDICARE & MEDICAID'S NATIONAL COVERAGE DETERMINATION
• PATIENT SELF-ADVOCACY IN DECISION MAKING RELATED TO POST-TREATMENT SURVEILLANCE FOR COLORECTAL CANCER
• ACCEPTABILITY AND EFFICACY OF A VIDEO-BASED PATIENT DECISION AID ABOUT LUNG CANCER SCREENING WITH LOW-DOSE COMPUTED TOMOGRAPHY
• PRIMARY CARE PHYSICIANS' LUNG CANCER SCREENING PRACTICES: COMPARISONS BEFORE AND AFTER THE CENTERS FOR MEDICARE & MEDICAID'S NATIONAL COVERAGE DETERMINATION
• PATIENT SELF-ADVOCACY IN DECISION MAKING RELATED TO POST-TREATMENT SURVEILLANCE FOR COLORECTAL CANCER
• TWO IS BETTER THAN ONE: AN ILLUSTRATION OF PAIRING SURVIVAL CURVES AND RECEIVER OPERATING CHARACTERISTIC CURVES TO ENHANCE DISEASE SIMULATION MODEL VALIDATION
• CHOOSING EVEN MORE WISELY: HEALTH SERVICES THAT IMPROVE HEALTH BUT WOULD STILL BE CONSIDERED LOW-VALUE PER COST-EFFECTIVENESS ANALYSIS
• IT'S ABOUT TIME: WOULD A NEW ACUTE STROKE TREATMENT TRIAL FOR THOSE 4.5-6.0 HOURS FROM STROKE ONSET BE GOOD VALUE FOR SAMPLE INFORMATION?
• TEACHING MDM INTEREST GROUP MEETING
• USING DISCRETE EVENT SIMULATION TO IMPROVE ACUTE STROKE CARE QUALITY MEASUREMENT
• DECISION THEORY DEMYSTIFIED
• METHODS OF DISEASE MODEL CALIBRATION: THEORY AND PRACTICE
• MODELING VALUE-BASED PAYMENT ADJUSTMENTS FOR TIMELY ACUTE STROKE CARE: COST-EFFECTIVENESS ANALYSIS MODELING MEETS PAY-FOR-PERFORMANCE
• CHOOSING EVEN MORE WISELY: HEALTH SERVICES THAT IMPROVE HEALTH BUT WOULD STILL BE CONSIDERED LOW-VALUE PER COST-EFFECTIVENESS ANALYSIS
• IT'S ABOUT TIME: WOULD A NEW ACUTE STROKE TREATMENT TRIAL FOR THOSE 4.5-6.0 HOURS FROM STROKE ONSET BE GOOD VALUE FOR SAMPLE INFORMATION?
• TEACHING MDM INTEREST GROUP MEETING
• USING DISCRETE EVENT SIMULATION TO IMPROVE ACUTE STROKE CARE QUALITY MEASUREMENT
• DECISION THEORY DEMYSTIFIED
• METHODS OF DISEASE MODEL CALIBRATION: THEORY AND PRACTICE
• MODELING VALUE-BASED PAYMENT ADJUSTMENTS FOR TIMELY ACUTE STROKE CARE: COST-EFFECTIVENESS ANALYSIS MODELING MEETS PAY-FOR-PERFORMANCE
• ‘EXPERT ADVICE' FOR DEVELOPING DECISION SUPPORT: A QUALITATIVE STUDY OF WOMEN WHO HAVE EXPERIENCED PERIVIABLE BIRTH
• EVALUATING SHARED DECISION-MAKING IN PERIVIABLE DELIVERY COUNSELING USING OBJECTIVE STRUCTURED CLINICAL EXAMINATIONS
• EVALUATING SHARED DECISION-MAKING IN TRIAL OF LABOR AFTER CESAREAN COUNSELING USING OBJECTIVE STRUCTURED CLINICAL EXAMINATIONS
• HOW DO WOMEN VALUE TRADE-OFFS IN MATERNAL-FETAL MORBIDITY AND MORTALITY?
• EVALUATING SHARED DECISION-MAKING IN PERIVIABLE DELIVERY COUNSELING USING OBJECTIVE STRUCTURED CLINICAL EXAMINATIONS
• EVALUATING SHARED DECISION-MAKING IN TRIAL OF LABOR AFTER CESAREAN COUNSELING USING OBJECTIVE STRUCTURED CLINICAL EXAMINATIONS
• HOW DO WOMEN VALUE TRADE-OFFS IN MATERNAL-FETAL MORBIDITY AND MORTALITY?
• AN EXPLORATION OF THE IMPACT OF NON-DIVISIBILITY, DIMINISHING MARGINAL RETURNS TO SCALE AND NON-MARGINAL BUDGET IMPACT ON THE COST-EFFECTIVENESS THRESHOLD USING A SIMULATION MODELLING APPROACH
• METHODS DEVELOPMENT IN ECONOMIC EVALUATION INTEREST GROUP MEETING
• PROBABILISTIC ONE-WAY SENSITIVITY ANALYSIS: A MODIFIED TORNADO DIAGRAM
• METHODS DEVELOPMENT IN ECONOMIC EVALUATION INTEREST GROUP MEETING
• PROBABILISTIC ONE-WAY SENSITIVITY ANALYSIS: A MODIFIED TORNADO DIAGRAM
• CORNEAL CROSS-LINKING VERSUS PENETRATING KERATOPLASTY IN THE TREATMENT OF KERATOCONUS: A COST-EFFECTIVENESS ANALYSIS
• WEIGHTING OF AHI SCORES AND SYMPTOMS IN THE DIAGNOSIS OF SLEEP APNEA BY SLEEP SPECIALISTS
• A SYSTEMATIC REVIEW AND META-ANALYSIS OF HEALTH UTILITIES IN CHRONIC HEPATITIS C PATIENTS
• CHALLENGES ON THE PATH TO REIMBURSEMENT OF ONCOLOGY DRUGS: INSIGHTS FROM THE COST-EFFECTIVENESS DECISIONS OF THE PAN-CANADIAN ONCOLOGY DRUG REVIEW
• DECISION MODELLING USING R
• WEIGHTING OF AHI SCORES AND SYMPTOMS IN THE DIAGNOSIS OF SLEEP APNEA BY SLEEP SPECIALISTS
• A SYSTEMATIC REVIEW AND META-ANALYSIS OF HEALTH UTILITIES IN CHRONIC HEPATITIS C PATIENTS
• CHALLENGES ON THE PATH TO REIMBURSEMENT OF ONCOLOGY DRUGS: INSIGHTS FROM THE COST-EFFECTIVENESS DECISIONS OF THE PAN-CANADIAN ONCOLOGY DRUG REVIEW
• DECISION MODELLING USING R
• AN E-LEARNING MODULE FOR SHARED DECISION MAKING WITH OLDER CANCER PATIENTS: IMPROVEMENT OF ONCOLOGISTS' SELF-REPORTED COGNITIONS AND BEHAVIOR
• DISCLOSING THE UNCERTAINTY ASSOCIATED WITH PROGNOSTIC ESTIMATES IN BREAST CANCER: CURRENT PRACTICES AND PATIENTS' PERCEPTIONS OF UNCERTAINTY
• MEASURING THE SHARED DECISION MAKING PROCESS: A SYSTEMATIC REVIEW OF INSTRUMENTS AND THEIR PSYCHOMETRIC PROPERTIES
• DISCLOSING THE UNCERTAINTY ASSOCIATED WITH PROGNOSTIC ESTIMATES IN BREAST CANCER: CURRENT PRACTICES AND PATIENTS' PERCEPTIONS OF UNCERTAINTY
• MEASURING THE SHARED DECISION MAKING PROCESS: A SYSTEMATIC REVIEW OF INSTRUMENTS AND THEIR PSYCHOMETRIC PROPERTIES
• COMBINING A COLORECTAL CANCER SCREENING DECISION AID AND PATIENT NAVIGATION IMPROVES DECISION MAKING PROCESSES AND SCREENING COMPLETION IN LINGUISTICALLY DIVERSE PRIMARY CARE PATIENTS
• EFFECT OF A LUNG CANCER SCREENING DECISION AID ON KNOWLEDGE OF SCREENING HARMS AND SCREENING PREFERENCE IN PRIMARY CARE PATIENTS
• EFFECT OF A LUNG CANCER SCREENING DECISION AID ON KNOWLEDGE OF SCREENING HARMS AND SCREENING PREFERENCE IN PRIMARY CARE PATIENTS
• COST-EFFECTIVENESS OF EXPANDED ADOLESCENT HPV VACCINE COVERAGE
• MEASURING PATIENT PREFERENCES FOR BARIATRIC SURGERY: A DISCRETE CHOICE EXPERIMENT
• USING CONJOINT ANALYSIS TO IDENTIFY FACTORS THAT INFLUENCE VACCINE ACCEPTANCE
• PANEL: RECOMMENDATIONS OF THE SECOND PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE
• PREFERENCES FOR HEALTH ECONOMICS PRESENTATIONS AMONG VACCINE POLICY MAKERS AND RESEARCHERS
• HEALTH UTILITIES OF RARE HERITABLE DISORDERS: APPROACHES FOR HEALTH STATE DESCRIPTIONS AND MEASURING SPILLOVER EFFECTS ON FAMILY MEMBERS
• MEASURING PATIENT PREFERENCES FOR BARIATRIC SURGERY: A DISCRETE CHOICE EXPERIMENT
• USING CONJOINT ANALYSIS TO IDENTIFY FACTORS THAT INFLUENCE VACCINE ACCEPTANCE
• PANEL: RECOMMENDATIONS OF THE SECOND PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE
• PREFERENCES FOR HEALTH ECONOMICS PRESENTATIONS AMONG VACCINE POLICY MAKERS AND RESEARCHERS
• HEALTH UTILITIES OF RARE HERITABLE DISORDERS: APPROACHES FOR HEALTH STATE DESCRIPTIONS AND MEASURING SPILLOVER EFFECTS ON FAMILY MEMBERS